Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-17-375059
Filing Date
2017-12-21
Accepted
2017-12-20 17:51:02
Documents
1
Group Members
MAK LLCMEH ACQUISITION CO.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d481043dsc13da.htm SC 13D/A 66940
  Complete submission text file 0001193125-17-375059.txt   68696
Mailing Address 555 TWIN DOLPHIN DRIVE SUITE 615 REDWOOD CITY CA 94065
Business Address 555 TWIN DOLPHIN DRIVE SUITE 615 REDWOOD CITY CA 94065 6504750158
Ocera Therapeutics, Inc. (Subject) CIK: 0001274644 (see all company filings)

EIN.: 631192270 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86177 | Film No.: 171267623
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3 LOTUS PARK, THE CAUSEWAY STAINES-UPON-THAMES SURREY X0 TW18 3AG
Business Address 3 LOTUS PARK, THE CAUSEWAY STAINES-UPON-THAMES SURREY X0 TW18 3AG 44-017-8463-6700
Mallinckrodt plc (Filed by) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | Fiscal Year End: 1229
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations